(secondQuint)Comparison of Efficacy and Safety of Norgestimate-ethinyl Estradiol and Cyproterone Acetate-ethinyl Estradiol in the Treatment of Acne Vulgaris.

 This study was to evaluate the efficacy and safety of TriCilest as comparted with Diane-35 among female patients with moderate acne vulgaris.

 The study design was double-blind, randomized, parallel and active controlled.

 The sponsor planned to recruit approximately 50 patients to complete 40 evaluable patients.

 At the end of the study, a total of 48 patients were randomized.

 TriCilest (noregestimate-ethinyl estradiol), 0.

18mg-0.

035mg or 0.

215mg-0.

035mg or 0.

25mg-0.

035mg, Oral admistration, The duration was three consecutive menstrual cycles.

.

 Comparison of Efficacy and Safety of Norgestimate-ethinyl Estradiol and Cyproterone Acetate-ethinyl Estradiol in the Treatment of Acne Vulgaris@highlight

The purpose of this study was to evaluate the effectiveness and safety of norgestimate-ethinyl estradiol as comparted with cyproterone acetate-ethinyl estradiol among female patients with moderate acne vulgaris.

